Allegiant Private Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$611K Buy
2,664
+143
+6% +$28.7K 0.1% 98
2021
Q1
$471K Buy
2,521
+713
+39% +$139K 0.09% 102
2020
Q4
$305K Buy
+1,808
New +$270K 0.06% 121

Other funds holding LLY

Allegiant Private Advisors's LLY Position: Q2 2021 in Review

Allegiant Private Advisors increased its Eli Lilly (LLY) stake by 5.7% in Q2 2021, buying an estimated $28.7K and bringing the position to 2,664 shares worth $611K. The position accounts for 0.1% of the portfolio, ranked #98.

Allegiant Private Advisors first reported a position in LLY in Q4 2020 and has held it in 3 quarters since. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.

  • Allegiant Private Advisors held 2,664 shares of Eli Lilly worth $611K as of Q2 2021.
  • Allegiant Private Advisors bought 143 Eli Lilly shares in Q2 2021, an estimated $28.7K.
  • Eli Lilly made up 0.1% of Allegiant Private Advisors's portfolio in Q2 2021, its #98 holding.
  • Allegiant Private Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 3 quarters since.
  • 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.

Based on Allegiant Private Advisors's 13F filing for Q2 2021, filed 7 Jul 2021.